邱騰華明啟程赴亞太經合會議

商務及經濟發展局局長邱騰華明日離港前赴泰國曼谷，出席星期六至星期日舉行的亞太區經濟合作組織貿易部長會議。　　 2022年亞太經合組織以開放．聯繫．均衡為主題，集中討論三個重點，即開放貿易和投資予各方機遇；恢復全方位互聯互通；以及促進均衡、可持續和包容發展。　　邱騰華將參與支持多邊貿易制度、疫下生活及疫後時代的討論環節，以及出席貿易部長與亞太經合組織商貿諮詢理事會的公私營對話環節。他此行也會與其他成員經濟體的貿易部長進行雙邊會談，就共同關心議題交流意見。　　逗留曼谷期間，邱騰華將會晤泰國政府高層官員及商界人士，介紹香港最新經貿情況，並出席由香港駐曼谷經濟貿易辦事處舉辦的香港特別行政區成立25周年慶祝活動。　　邱騰華星期日晚上返港。他離港期間，商經局副局長陳百里署理局長職務。
http://dlvr.it/SQb0RF

此網誌的熱門文章

香港 Backlinks 網站，中文本地 SEO 必備

市面上的 Backlinks 多數來自外國英文網站，對於香港網站未能精準地改善中文版 Google 排名，有見及此，有 IT 公司推出為香港公司而設的繁體中文 Backlinks 服務，在 100 多個高誠信度的新聞網站刊登文案，增加香港 Backlinks ，大大提升中文版 Google 排名。新聞網站包括： https://www.buyinghongkong.com https://www.eatinghongkong.com https://www.playinghongkong.com https://www.relaxhongkong.com https://www.hk-bfn.com https://www.hk-cln.com https://www.hk-swn.com https://www.biznews.org.hk https://www.building.org.hk https://www.citylife.org.hk https://www.educate.org.hk https://www.healthy.org.hk https://www.hongkong.org.hk https://www.lohas.org.hk https://www.funding.org.hk https://www.tvp.org.hk https://www.bud.org.hk https://www.smefund.org.hk https://news.business138.com https://news.corporate138.com https://news.company138.com https://news.product138.com https://news.service138.com https://news.solution138.com https://news.website138.com https://news.supplier138.com https://news.vendor138.com https://news.directory138.com https://news.business228.com https:

Hong Kong Science Park: Healthy ecosystem cultivates powerful global collaboration

(English) A healthy ecosystem cultivates powerful global collaboration BeiGene, a global commercial-stage biotech company, has entered a worldwide strategic collaboration with our park company InnoRNA to take mRNA-based therapeutics to the next level. bit.ly/3yW8S0f You probably heard about Messenger RNA (mRNA). It has been used in some of the leading COVID vaccines. Q: What's mRNA's superpower? A: It directs human cells to generate proteins to help our immune systems develop antibodies for disease prevention and treatment. Q: What's InnoRNA's superpower? A: The platform developed by CEO Dr Li Linxian makes the mRNA less fragile, and the technology can rapidly and accurately identify safe and effective mRNA carriers for clinical treatment. Q: What's HKSTP's superpower? A: Hong Kong is the world's number two biotech funding hub. We will leave you to find out more! Follow our page for more biotech news in Hong Kong and beyond. Reference : ht

HKSTP Park Company Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform

Congratulations! Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform and the lentiviral vector production system developed by their team based at our Park. Millions of people globally are suffering from different type of cancers. Our park company, Eurekabio, specialises in manufacturing supplies and platform for Cell and Gene Therapies (CGT). Thank you Eurekabio for playing a pivotal role in accelerating the development of CGT through automation - Standardising cell processing procedures - Increasing efficiency - Reducing human error and contamination Learn more: https://lnkd.in/gEGmc7Vz Follow our page for more fundraising news happening in our thriving ecosystem. More Information : https://www.hkstp.org/what-we-offer/institute-for-translational-research-overview/

香港新聞網 Service368

搜尋此網誌